Based in Indianapolis with operations in Wuhan, China, Waterstone Pharmaceuticals is an emerging leader in providing products and services to the global life sciences industry.

In 2010, Waterstone Pharmaceuticals launched its new R&D center and new API manufacturing facility meeting ICH Q7 and US FDA cGMP guidelines.

From early stage discovery to commercial programs, Waterstone Pharmaceuticals continues to invest into technologies and capabilities to serve the global pharmaceutical industry.